Medscape June 14, 2020
Miriam E. Tucker

The Abbott FreeStyle Libre glucose monitoring system significantly reduced hospitalizations for diabetic ketoacidosis (DKA), diabetes-related emergencies, and all-cause hospitalizations among patients with diabetes, data from two new studies indicate.

The results were presented June 13 during the virtual American Diabetes Association (ADA) 80th Scientific Sessions.

One large database analysis, from France, revealed that use of the Libre system halved hospitalization rates for DKA among people with type 1 or type 2 diabetes.

In the other study, a retrospective analysis of data from over 1200 insulin-treated individuals with type 2 diabetes in the United States, use of the Libre was associated with significant reductions in both hospitalizations for acute diabetes-related emergency events and all-cause hospitalizations.

The Libre system reads...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Health System / Hospital, Patient / Consumer, Physician, Provider, Technology, Wearables
Low-cost wearable sensors may lead to better Parkinson’s care
Fitness trackers and phones can help monitor multiple sclerosis
Digital Phenotyping: emerging HealthTech sub sector is 'one to watch in 2024 and 2025'
Apple Watch’s ‘Foggy’ gets FDA medical device listing for Parkinson’s
At-Home Patients and AI: Q&A with Riccardo Butta

Share This Article